 |
LG Life sciences completed MOU with Beijing Pharmaceutical Group for R&D, sales/licensing/partnership in China, and other various fields.
Beijing Pharmaceutical Group is one of three big pharmceutical groups in China and has 21,000 employees with sales of 4,6 trillion won.
LG Life Sciences CEO Kim, In Chull stated This MOU would be a great opportunity to contribute to the growth of pharmaceutical industryf in both Korea and China, and for LG Life Sciences to expand market to China which is third greatest market in the world.
|
